Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Analyzes emerging technologies, patent activity & competitive developments shaping next generation of decentralized, highly automated manufacturing systems
-
Commercial availability expected in August as the Company advances the rollout of the highest-dose FDA-approved naloxone hydrochloride nasal spray U.S. naloxone market totals ~$144 million in annual...
-
Austin, TX, USA, July 08, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Microfluidic Devices Market Size, Trends and Insights By Device Type (Chips,...
-
Austin, TX, USA, July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Infant Medicine Syringes Market Size, Trends and Insights By Type (Oral Syringes,...
-
Austin, TX, USA, July 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Beadlets Capsule Market Size, Trends and Insights By Type (Vitamin Beadlets,...
-
SERB Pharmaceuticals has completed the acquisition of development and commercialization rights to Idefirix (imlifidase) in Europe
-
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
-
In Vitro Toxicity Testing Technologies Advance as Drug Developers Seek Faster, More Predictive Safety Screening.
-
Austin, TX, USA, June 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Laboratory Equipment Services Market Size, Trends and Insights By Service Type...
-
Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, autoimmune and fibro-inflammatory diseases Company...